Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

R. Lichtenstein, Gary; G. Feagan, Brian; D. Cohen, Russell; Salzberg, Bruce; H. Diamond, Robert; Price, Samiyeh; Langholff, Wayne; Londhe, Anil; J. Sandborn, William

doi:10.1038/ajg.2012.218

Public

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

Published in The American Journal of Gastroenterology • Aug 14, 2012

Authors:

Gary R. Lichtenstein

Brian G. Feagan

Russell D. Cohen

Abstract

OBJECTIVES: The objective of this study was to contribute long-term safety data for infliximab and other therapies in Crohn's disease (CD). METHODS: We prospectively evaluated CD patients enrolled in the large, observational Crohn's Therapy, Resource, Evaluation, and Assessment Tool registry, establ...

Subject

Medicine

Infliximab

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!